Export 2801 results:
Author Keyword [ Title(Desc)] Type Year
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
I. A. C. Arnoldussen, Sundh, V., Bäckman, K., Kern, S., Östling, S., Blennow, K., Zetterberg, H., Skoog, I., Kiliaan, A. J., and Gustafson, D. R., A 10-Year Follow-Up of Adiposity and Dementia in Swedish Adults Aged 70 Years and Older., J Alzheimers Dis, vol. 63, no. 4, pp. 1325-1335, 2018.
L. Wu, Liu, J., Feng, X., Dong, J., Qin, W., Liu, Y., Wang, J., Lu, J., Chen, K., Wang, Y., and Jia, J., 11C-CFT-PET in Presymptomatic FTDP-17: A Potential Biomarker Predicting Onset., J Alzheimers Dis, vol. 61, no. 2, pp. 613-618, 2018.
H. Jin Kim, Cho, H., Werring, D. J., Jang, Y. Kyoung, Kim, Y. Jin, San Lee, J., Lee, J., Jun, S., Park, S., Ryu, Y. Hoon, Choi, J. Yong, Cho, Y. Seok, Moon, S. Hwan, Na, D. L., Lyoo, C. Hyoung, and Seo, S. Won, 18F-AV-1451 PET Imaging in Three Patients with Probable Cerebral Amyloid Angiopathy., J Alzheimers Dis, vol. 57, no. 3, pp. 711-716, 2017.
M. Khosravi, Peter, J., Wintering, N. A., Serruya, M., Shamchi, S. Pourhassan, Werner, T. J., Alavi, A., and Newberg, A. B., 18F-FDG Is a Superior Indicator of Cognitive Performance Compared to 18F-Florbetapir in Alzheimer's Disease and Mild Cognitive Impairment Evaluation: A Global Quantitative Analysis., J Alzheimers Dis, vol. 70, no. 4, pp. 1197-1207, 2019.
N. Smailagic, Lafortune, L., Kelly, S., Hyde, C., and Brayne, C., 18F-FDG PET for Prediction of Conversion to Alzheimer's Disease Dementia in People with Mild Cognitive Impairment: An Updated Systematic Review of Test Accuracy., J Alzheimers Dis, vol. 64, no. 4, pp. 1175-1194, 2018.
C. M. Lee, Jacobs, H. I. L., Marquié, M., Becker, J. A., Andrea, N. V., Jin, D. S., Schultz, A. P., Frosch, M. P., Gómez-Isla, T., Sperling, R. A., and Johnson, K. A., 18F-Flortaucipir Binding in Choroid Plexus: Related to Race and Hippocampus Signal., J Alzheimers Dis, vol. 62, no. 4, pp. 1691-1702, 2018.
L. Flem Kalheim, Fladby, T., Coello, C., Bjørnerud, A., and Selnes, P., [18F]-Flutemetamol Uptake in Cortex and White Matter: Comparison with Cerebrospinal Fluid Biomarkers and [18F]-Fludeoxyglucose., J Alzheimers Dis, vol. 62, no. 4, pp. 1595-1607, 2018.
M. T. Fodero-Tavoletti, Okamura, N., Furumoto, S., Mulligan, R. S., Connor, A. R., McLean, C. A., Cao, D., Rigopoulos, A., Cartwright, G. A., O'Keefe, G., Gong, S., Adlard, P. A., Barnham, K. J., Rowe, C. C., Masters, C. L., Kudo, Y., Cappai, R., Yanai, K., and Villemagne, V. L., 18F-THK523: a novel in vivo tau imaging ligand for Alzheimer's disease., Brain, vol. 134, no. Pt 4, pp. 1089-100, 2011.
H. - L. Gao, Li, C., Nabeka, H., Shimokawa, T., Wang, Z. - Y., Cao, Y. - M., and Matsuda, S., An 18-mer Peptide Derived from Prosaposin Ameliorates the Effects of Aβ1-42 Neurotoxicity on Hippocampal Neurogenesis and Memory Deficit in Mice., J Alzheimers Dis, vol. 53, no. 3, pp. 1173-92, 2016.
C. D. Pereira, Martins, F., Wiltfang, J., Silva, O. A. B. da Cru, and Rebelo, S., ABC Transporters Are Key Players in Alzheimer's Disease., J Alzheimers Dis, vol. 61, no. 2, pp. 463-485, 2018.
A. Boehm-Cagan, Bar, R., Liraz, O., Bielicki, J. K., Johansson, J. O., and Michaelson, D. M., ABCA1 Agonist Reverses the ApoE4-Driven Cognitive and Brain Pathologies., J Alzheimers Dis, vol. 54, no. 3, pp. 1219-1233, 2016.
N. F. Fitz, Carter, A. Y., Tapias, V., Castranio, E. L., Kodali, R., Lefterov, I., and Koldamova, R., ABCA1 Deficiency Affects Basal Cognitive Deficits and Dendritic Density in Mice., J Alzheimers Dis, vol. 56, no. 3, pp. 1075-1085, 2017.
Y. Lamartinière, Boucau, M. - C., Dehouck, L., Krohn, M., Pahnke, J., Candela, P., Gosselet, F., and Fenart, L., ABCA7 Downregulation Modifies Cellular Cholesterol Homeostasis and Decreases Amyloid-β Peptide Efflux in an in vitro Model of the Blood-Brain Barrier., J Alzheimers Dis, vol. 64, no. 4, pp. 1195-1211, 2018.
N. Sinha, Berg, C. N., Shaw, A., and Gluck, M. A., ABCA7 Genotype Moderates the Effect of Aerobic Exercise Intervention on Generalization of Prior Learning in Healthy Older African Americans., J Alzheimers Dis, vol. 74, no. 1, pp. 309-318, 2020.
Q. - F. Zhao, Wan, Y., Wang, H. - F., Sun, F. - R., Hao, X. - K., Tan, M. - S., Tan, C. - C., Zhang, D. - Q., Tan, L., and Yu, J. - T., ABCA7 Genotypes Confer Alzheimer's Disease Risk by Modulating Amyloid-β Pathology., J Alzheimers Dis, vol. 52, no. 2, pp. 693-703, 2016.
Y. H. Fu, Hsiao, J. - H. T., Paxinos, G., Halliday, G. M., and Kim, W. Scott, ABCA7 Mediates Phagocytic Clearance of Amyloid-β in the Brain., J Alzheimers Dis, vol. 54, no. 2, pp. 569-84, 2016.
M. Domínguez-Prieto, Velasco, A., Vega, L., Tabernero, A., and Medina, J. M., Aberrant Co-localization of Synaptic Proteins Promoted by Alzheimer's Disease Amyloid-β Peptides: Protective Effect of Human Serum Albumin., J Alzheimers Dis, vol. 55, no. 1, pp. 171-182, 2017.
B. Nouriziabari, Sarkar, S., Tanninen, S. E., Dayton, R. D., Klein, R. L., and Takehara-Nishiuchi, K., Aberrant Cortical Event-Related Potentials During Associative Learning in Rat Models for Presymptomatic Stages of Alzheimer's Disease., J Alzheimers Dis, vol. 63, no. 2, pp. 725-740, 2018.
L. Ni, Liu, R., Yin, Z., Zhao, H., Nedelska, Z., Hort, J., Zhou, F., Wu, W., Zhang, X., Li, M., Yu, H., Zhu, B., Xu, Y., and Zhang, B., Aberrant Spontaneous Brain Activity in Patients with Mild Cognitive Impairment and concomitant Lacunar Infarction: A Resting-State Functional MRI Study., J Alzheimers Dis, vol. 50, no. 4, pp. 1243-54, 2016.